Cannabis during pregnancy: risks & study situation
- THC crosses the placental barrier and binds to CB1 receptors in the fetal brain from the first trimester onwards
- No established safe limit – the only evidence-based limit is total abstinence
- Breastfeeding: THC is excreted in breast milk and is still detectable months after abstinence
Cannabis during pregnancy: clear risk findings
Cannabis is the most commonly consumed illegal substance during pregnancy. In countries with legalization (USA, Canada), consumption by pregnant women has increased significantly. At the same time, the scientific evidence on risks to the fetus and newborn is clear and consistent: cannabis during pregnancy is associated with multiple developmental risks.
Main mechanism: THC is highly lipophilic and crosses the placental barrier easily. The fetal endocannabinoid system already develops in the first trimester – CB1 receptors have been detected in fetal neurons and in the placenta. Exogenous THC intervenes directly in the ECS-controlled brain development of the fetus.
Study situation: Risks for the child
| Study | Design | Result |
|---|---|---|
| Fried et al. 2003 (Neurotoxicol Teratol) | Ottawa Prenatal Prospective Study, longitudinal up to 18 years, n=70+ | Prenatal cannabis exposure: attention deficits, executive function deficits, poorer school performance in childhood and adolescence |
| Gunn et al. 2016 (BMJ Open) | Systematic review, 24 studies | Cannabis in pregnancy: increased risk of maternal anemia, SGA (small for gestational age, -109g birth weight), stillbirth association |
| Corsi et al. 2019 (JAMA) | Canadian cohort, n=661,000 births | Cannabis exposure during pregnancy: significantly increased risk of preterm birth (+41%) and SGA (+53%); still significant after controlling for tobacco |
| Sharapova et al. 2018 (Pediatrics) | PRAMS cohort, n=16,000, USA | Children of prenatal cannabis exposure: increased likelihood of NICU admission, respiratory problems at birth |
Premature birth risk and birth weight
The most robust finding is the increased risk of premature birth and SGA. Corsi 2019 (JAMA, n=661,000) is the largest study to date and shows after careful confounder control:
– +41 % risk of premature birth (before 37 weeks’ gestation)
– +53 % SGA risk (weight below 10th percentile)
Premature birth and low birth weight are themselves risk factors for neurological development problems, respiratory disorders and later chronic diseases.
Neuronal development: long-term consequences
The Fried team followed children of prenatal cannabis exposure over 18 years. Findings:
– Deficits in attention and executive control (planning, impulse inhibition)
– Higher impulsivity and more ADHD-like symptoms
– Tend to perform worse at school
– THC disrupts ECS-driven neuronal migration and synapse formation in the fetal brain
Breastfeeding and cannabis
THC passes into the mother’s milk and accumulates there (fat content of the milk) to concentrations well above the mother’s blood plasma level:
– THC in breast milk: up to 8× higher concentration than in maternal blood
– Half-life in breast milk: 20+ hours
– Newborn liver metabolizes cannabinoids significantly slower than adults → Accumulation
– Studies (Baker 2018, Pediatrics): THC detectable in breast milk 6 days after last use
Recommendation of all professional societies (ACOG, AAP, DGGG): No cannabis during pregnancy and breastfeeding.
CBD during pregnancy
CBD is not safe. Although CBD is less psychoactive than THC, human studies on safety in pregnancy are completely lacking. Animal models also show worrying effects for CBD on placental function (TRPV1 overactivation → vasoconstriction). The FDA and European authorities explicitly advise against CBD during pregnancy and breastfeeding.
- Cannabis and adolescents
Cannabis & fertility
FAQ: Cannabis during pregnancy
Summary
Cannabis during pregnancy is clearly risky: THC crosses the placenta, disrupts fetal ECS-controlled brain development, significantly increases the risk of premature birth and SGA. Long-term studies show attention and executive function deficits in the child. Breastfeeding transmits THC via breast milk in high concentrations. CBD is also contraindicated – no human data on safety. Cannabis and adolescents covers the further developmental phase; cannabis dependence for affected mothers who want to stop.
Cannabis for restless legs: CBD, dopamine & studies
Cannabis & bones: CB2, osteoporosis & bone healing
Cannabis & testosterone: effect on male fertility
Cannabis quality: laboratory tests, pesticides & contamination
Home cannabis cultivation: rules according to CanG
Cannabis microdosing: low doses of THC & CBD
